Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01702610 : Phase II Trial of Neo-adjuvant Temozolomide Prior to Combined Temozolomide and Concurrent Accelerated Hypofractionated External Beam Radiotherapy Followed by Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Age: 18 years or older

- Histological confirmation of supratentorial GBM

- KPS > 60

- Neurological function 0 or 1

- Adequate bone marrow as defined below:

- absolute neutrophil count (ANC) > 1500 cells/mm3

- platelets > 100,000 cells/mm3

- hemoglobin > 10g/dl

- Adequate renal function as defined below:

- BUN < 25mg/dl within 14 days prior to study registration

- creatinine of 63 to 103 umol/L within 14 days prior to study registration

- Adequate hepatic function as defined below:

- Bilirubin of 3 to 21 umol/L within 14 days prior to study registration

- ALT & AST < 3xnormal range within 14 days prior to study registration

- Neoadjuvant TMZ to start within 3 weeks of surgery/biopsy if no resection was deemed
feasible

- A diagnostic contrast-enhanced MRI or CT scan of the brain must be performed
preoperatively and postoperatively.

- History, physical and neurological examination within 14 days prior to study
registration.

- For females of child-bearing potential, negative pregnancy test within 72 hours prior
to starting TMZ.

- Able to sign an informed study-specific consent

Exclusion Criteria:

- Margin of contrast-enhanced residual mass closer than 15mm from the optic chiasm or
optic nerves.

- Prior invasive malignancy, unless disease-free for >3years

- Recurrent or multifocal GBM

- Severe co-morbidities such as

- unstable angina

- transmural myocardial infarction within 6 months

- COPD at the time of registration

- Hepatic insufficiency

- Bacterial or fungal infection requiring IV antibiotics at the time of registration

- Acquired Immune Deficiency Syndrome (AIDS)

- Major medical illnesses or psychiatric impairments

- Pregnant women or lactating women
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01702610      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740